- Home
- TKNO vs ABSI Comparison
TKNO vs ABSI Comparison
Compare TKNO & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TKNO
- ABSI
- Stock Information
- Founded
- TKNO 1996
- ABSI 2011
- Country
- TKNO United States
- ABSI United States
- Employees
- TKNO N/A
- ABSI N/A
- Industry
- TKNO Medicinal Chemicals and Botanical Products
- ABSI Biotechnology: Pharmaceutical Preparations
- Sector
- TKNO Health Care
- ABSI Health Care
- Exchange
- TKNO Nasdaq
- ABSI Nasdaq
- Market Cap
- TKNO 256.9M
- ABSI 338.0M
- IPO Year
- TKNO 2021
- ABSI 2021
- Fundamental
- Price
- TKNO $4.35
- ABSI $2.39
- Analyst Decision
- TKNO
- ABSI Strong Buy
- Analyst Count
- TKNO 0
- ABSI 5
- Target Price
- TKNO N/A
- ABSI $7.98
- AVG Volume (30 Days)
- TKNO 224.0K
- ABSI 4.4M
- Earning Date
- TKNO 08-07-2025
- ABSI 08-12-2025
- Dividend Yield
- TKNO N/A
- ABSI N/A
- EPS Growth
- TKNO N/A
- ABSI N/A
- EPS
- TKNO N/A
- ABSI N/A
- Revenue
- TKNO $38,923,000.00
- ABSI $4,138,000.00
- Revenue This Year
- TKNO $9.52
- ABSI $44.71
- Revenue Next Year
- TKNO $15.20
- ABSI $374.26
- P/E Ratio
- TKNO N/A
- ABSI N/A
- Revenue Growth
- TKNO 11.40
- ABSI 27.32
- 52 Week Low
- TKNO $4.00
- ABSI $2.01
- 52 Week High
- TKNO $10.37
- ABSI $6.33
- Technical
- Relative Strength Index (RSI)
- TKNO 43.35
- ABSI 33.33
- Support Level
- TKNO $4.22
- ABSI $2.50
- Resistance Level
- TKNO $4.94
- ABSI $2.73
- Average True Range (ATR)
- TKNO 0.29
- ABSI 0.18
- MACD
- TKNO -0.00
- ABSI -0.04
- Stochastic Oscillator
- TKNO 16.75
- ABSI 1.94
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.